Use of methylphenidate in attention-deficit hyperactivity disorder

被引：0

作者：

Jean-Tron, Maria G. ^{[1
]}

Marquez-Gonzalez, Horacio ^{[1
]}

Barragan-Perez, Eduardo ^{[2
]}

Barajas-Nava, Leticia A. ^{[3
]}

机构：

[1] Hosp Infantil Mexico Dr Federico Gomez, Ctr Asociado Cochrane, Serv Invest Clin, Mexico City, DF, Mexico

[2] Hosp Infantil Mexico Dr Federico Gomez, Ctr Asociado Cochrane, Dept Neurol Pediat, Mexico City, DF, Mexico

[3] Hosp Infantil Mexico Dr Federico Gomez, Ctr Asociado Cochrane, Unidad Invest Med Basada Evidencias, Mexico City, DF, Mexico

来源：

BOLETIN MEDICO DEL HOSPITAL INFANTIL DE MEXICO | 2020年 / 77卷 / 01期

关键词：

Methylphenidate; Children; Attention deficit disorder with hyperactivity;

D O I：

10.24875/BMHIM.19000111

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Hospital Infantil de Mexico Federico Gomez is affiliated with the Cochrane Collaboration. As part of the activities of the Cochrane Center of the Hospital Infantil de Mexico, the use of systematic reviews in health decision making is promoted. With this objective, summaries of Cochrane systematic reviews on relevant topics will be periodically published to support the clinical practice.

引用

页码：42 / 45

页数：4

共 6 条

[1]

[Anonymous], 2014, Cochrane handbook for systematic reviews of interventions version 5.1.0

[2]

[Anonymous], 2012, Cochrane Database of Systematic Reviews, DOI DOI 10.1002/14651858.CD009885

[3]

Caballero J, 2017, INTEGR PHARM RES PRA, V6, P163, DOI 10.2147/IPRP.S142576

[4]

National Institute for Health and Care Excellence, 2018, Attention deficit hyperactivity disorder: diagnosis and management (NG87)

[5] ADHD in children and young people: prevalence, care pathways, and service provision [J].

Sayal, Kapil ;

Prasad, Vibhore ;

Daley, David ;

Ford, Tamsin ;

Coghill, David .

LANCET PSYCHIATRY, 2018, 5 (02) :175-186

[6]

The Nordic Cochrane Centre, 2014, COCHRANE COLLABORATI

← 1 →